PD-L1 is widely expressed in tumor cells, and it binds to PD-1 on the surface of T lymphocytes to transmit inhibitory signals to T cells, thereby inactivating T lymphocyte immune reactions [14, 15]. This evidence concerns the gene CD274 and neoplasm.